期刊文献+

干扰素-α通过PI3K/Akt信号通路对肝癌细胞SMCC-7721的影响及相关性 被引量:3

Effect of IFN-α on hepatic cancer SMCC-7721 cell via PI3K/Akt signaling pathway and related mechanism research
原文传递
导出
摘要 目的 探讨干扰素-α(IFN-α)通过PI3K/Akt信号通路对肝癌细胞SMCC-7721的影响及相关分子机制.方法 通过MTT法检测IFN-α对SMCC-7721细胞活力的影响;利用流式细胞术检测IFN-α对SMCC-7721细胞周期的影响;Western印迹分析脂酰肌醇3激酶(PI3K)/蛋白激酶B(Akt)通路的激活状况及其下游靶基因糖原合成酶激酶-3β(GSK-3β)、细胞周期蛋白D1(Cyclin Dl)、p21的表达变化,以及C-myc和Survivin的表达变化情况.结果 MTT结果显示IFN-α(5、10、15 U/L)均可显著抑制细胞的活力(P<0.05),并且在48 h抑制程度最高,抑制率分别为(10.5±3.1)%、(24.3±4.6)%、(39.4±5.5)%(P<0.01).流式细胞仪结果显示:与对照组比较,(5、10、15 U/L) IFN-α可使细胞周期阻滞在G1期,Western印迹结果显示:(10、15 U/L) IFN-α显著下调PI3K表达并抑制GSK-3β磷酸化(P<0.05),(5、10、15 U/L) IFN-α均可抑制Akt磷酸化,并下调Cyclin D1量及上调p21的表达(P<0.05),(10、15 U/L) IFN-α均可下调C-myc和Survivin的表达(P<0.05).结论 IFN-α可抑制肝癌细胞SMCC-7721生长和增殖,阻断PI3 K/Akt信号通路传导,影响Cyclin D1、p21、C-myc、Survivin等分子表达. Objective This study explored how interferon alpha (IFN-α) influenced liver cancer SMCC-7721 cell via PI3K/Akt signaling pathway.Methods The effect of IFN-α on the viability of SMCC-7721 cell was measured by MTT assay.The effect of IFN-α on SMCC-7721 cell cycle was measured by flow cytometry.The activation of PI3K/Akt signaling pathway and downstream target genes expression level of glycogen synthase kinase 3 beta (GSK-3β),and cell cycle protein (Cyclin D1),p21,C-myc,Survivin were assayed by Western blot.Results MTT assay indicated IFN-α (5,10,15 U/L) could inhibit SMCC-7721 cell viability,and the inhibitory rate was the highest at 48 h.IFN-α made SMCC-7721 cell arrested.Western blotting assays presented IFN-α could down-regulate expression of PI3K and suppress the phosphorylation of Akt,and then inhibit phosphorylation of GSK-3β.It could also reduce the expression levels of Cyclin D1,C-myc and Survivin but increase the level of p21.Conclusion These results suggested IFN-α could depress the growth and proliferation of liver cancer SMCC-7721 cell via blocking PI3K/Akt signaling pathway,and the molecular proteins Cyclin D1,p21,C-myc,Survivin were involved.
作者 闫琳 师广勇
出处 《中华医学杂志》 CAS CSCD 北大核心 2015年第36期2960-2963,共4页 National Medical Journal of China
关键词 干扰素-Α 肝癌细胞SMCC-7721 PI3K/AKT信号通路 IFN-α Liver'cancerceilSMCC-7721 PI3K/Akt signaling pathway
  • 相关文献

参考文献6

二级参考文献77

  • 1陈庆永,王春友,吴河水,陈道达.外源性PTEN基因诱导人乳腺癌MDA468细胞凋亡[J].中华医学杂志,2005,85(1):33-36. 被引量:12
  • 2全国肿瘤登记中心.中国肿瘤登记工作指导手册[M].北京:中国协和医科大学出版社,2004.48-50. 被引量:63
  • 3Fisher B, Bryant J, Wolmark N, et al. Effect of preoperative chemotherapy on the outcome of women with operable breast cancer. J Clin Oncol, 1998, 16:2672-2685. 被引量:1
  • 4Bear HD, Anderson S, Smith RE, et al. Sequential preoperative or postoperative docetaxel added to preoperative doxorubicin plus cyclophospbamide for operable breast cancer: national surgical adjuvant breast and bowel project protocol B-27. J Clin Oncol, 2006, 24:2019-2027. 被引量:1
  • 5Tewari M, Krishnamurthy A, Shukla HS. Predictive markers of response to neoadjuvant chemotherapy in breast cancer. Surg Oncol, 2008, 17:301-311. 被引量:1
  • 6Castaneda CA, Cortes-Funes H, Gomez HL, et al. The phosphatidyl inositol 3-kinase/AKT signaling pathway in breast cancer. Cancer Metastasis Rev, 2010, 29:751-759. 被引量:1
  • 7Swanton C, Marani M, Pardo O, et al. Regulators of mitotic arrest and ceramide metabolism are determinants of sensitivity to paclitaxel and other chemotherapeutic drugs. Cancer Cell, 2007, 11:498-512. 被引量:1
  • 8Campone M, Levy V, Bourbouloux E, et al. Safety and pharmacokinetics of paclitaxel and the oral mTOR inhibitor everolimus in advanced solid tumours. Br J Cancer, 2009, 100: 315-321. 被引量:1
  • 9Therasse P, Arbuck SG, Eisenhauer EA, et al. New guidelines to evaluate the response to treatment in solid tumors. European organization for research and treatment of cancer, National Cancer Institute of the United States, National Cancer Institute of Canada. J Natl Cancer Inst, 2000, 92:205-216. 被引量:1
  • 10Duch J, Fuster D, Mufioz M, et al. 18F-FDGPET/CT for early prediction of response to neoadjuvant chemotherapy in breast cancer. Eur J Nucl Med Mol Imaging, 2009, 36:1551-1557. 被引量:1

共引文献897

同被引文献17

引证文献3

二级引证文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部